1. Home
  2. INFU vs FLC Comparison

INFU vs FLC Comparison

Compare INFU & FLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INFU
  • FLC
  • Stock Information
  • Founded
  • INFU 2005
  • FLC 2003
  • Country
  • INFU United States
  • FLC United States
  • Employees
  • INFU N/A
  • FLC N/A
  • Industry
  • INFU Medical/Dental Instruments
  • FLC Trusts Except Educational Religious and Charitable
  • Sector
  • INFU Health Care
  • FLC Finance
  • Exchange
  • INFU Nasdaq
  • FLC Nasdaq
  • Market Cap
  • INFU 189.2M
  • FLC 176.2M
  • IPO Year
  • INFU N/A
  • FLC N/A
  • Fundamental
  • Price
  • INFU $8.12
  • FLC $17.01
  • Analyst Decision
  • INFU
  • FLC
  • Analyst Count
  • INFU 0
  • FLC 0
  • Target Price
  • INFU N/A
  • FLC N/A
  • AVG Volume (30 Days)
  • INFU 68.4K
  • FLC 37.8K
  • Earning Date
  • INFU 03-13-2025
  • FLC 01-01-0001
  • Dividend Yield
  • INFU N/A
  • FLC 6.64%
  • EPS Growth
  • INFU 60.96
  • FLC N/A
  • EPS
  • INFU 0.07
  • FLC N/A
  • Revenue
  • INFU $132,783,999.00
  • FLC N/A
  • Revenue This Year
  • INFU $10.23
  • FLC N/A
  • Revenue Next Year
  • INFU $8.80
  • FLC N/A
  • P/E Ratio
  • INFU $115.57
  • FLC N/A
  • Revenue Growth
  • INFU 8.17
  • FLC N/A
  • 52 Week Low
  • INFU $5.74
  • FLC $12.62
  • 52 Week High
  • INFU $9.97
  • FLC $15.45
  • Technical
  • Relative Strength Index (RSI)
  • INFU 48.91
  • FLC 58.36
  • Support Level
  • INFU $7.86
  • FLC $16.87
  • Resistance Level
  • INFU $8.25
  • FLC $17.08
  • Average True Range (ATR)
  • INFU 0.28
  • FLC 0.20
  • MACD
  • INFU 0.02
  • FLC 0.04
  • Stochastic Oscillator
  • INFU 70.00
  • FLC 88.71

About INFU InfuSystems Holdings Inc.

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.

About FLC Flaherty & Crumrine Total Return Fund Inc

Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.

Share on Social Networks: